This website use cookies

We use cookies to analyse our traffic and improve the website navigation and our marketing strategy. We do not share or sell information about your use of our site.

close

Connect with Mevia

We are glad you want to connect with us! Fill out the form and we'll contact you to set up a call or meeting.

close

Subscribe for Mevia's newsletter

Fill out the form and get news about our journey in Mevia's monthly newsletter.

An innovative adherence partner

Mevia provides a customised and reliable end-to-end solution to ensure medical adherence, safe data management and patient support in clinical trials.

An end-to-end solution

Collect adherence data with Mepill or Medose. Follow the data in Mevia’s dashboard and app in real-time.

Mevias product system

Our solutions

Collect adherence data

Collect real-time adherence data with Mepill or Medose. Cellular devices that connect to medicine packages and automatically let you know when a dose is taken. Choose between Mepill, for single-pill blisters and Medose, for multiple pill dose-dispenser.

Follow adherence data in real-time

View the collected real-time adherence data in our digital dashboard. It allows administrative users to follow-up on adherence behaviours and know when extra counselling is needed. Extract customised PDF:s for accessible material to share.

Provide treatment support

Provide customised treatment support and collect the health data you need with our easy-to-use application or SMS to Web-set up. The doses are automatically updated in the application when taken by Mepill or Medose.

Mevia is a trusted partner to Merck in a global multi-centre clinical study where they support patient adherence and safe data management
Merck KGaA, Darmstadt, Germany

Mevia's collaborative and responsive approach enables us to improve products and services for our customers and their patients
Jones healthcare group

Know which pill is taken at what time with

Mepill logo

A sustainable option for smart packaging with no single-use electronics that guarantees reliable data collection through a cellular connection.

mepill
Mepill device with pill pack and a tablet taken

Increasing the effectiveness of adherence interventions may have a far greater impact on the health of the population than any improvement in specific medical treatments.
World Health Organisation
Older person hugging a younger girl

A 1% improvement in adherence gives an average cost saving of 335 700 $ US dollar in clinical trial phase III.

References: M.Alsumidaie (2017) Non-Adherence: A Direct Influence on Clinical Trial Duration and Cost.
Average cost savings with 1% improved adherence in clinical trials (US dollar)
A statistic table showing many saved if adherence is improved with 1 %

Working with clinical trials?

Mevia is providing patient support in multi-centre clinical studies with a global reach. We ensure patient adherence and safe data management as a partner to the pharmaceutical industry, CRO’s and CMO's.

Reliable real-time adherence data

Use patented technology to accurately register every dose taken

Follow adherence behaviours in real-time

Data to maintain statistical power with fewer participants

Provide user friendly treatment support

Increase well-being and patient safety

Provide support to increase adherence to treatment

Material to engage and discuss around adherence behaviours

Digitalise patient diary and data collection

Save time, money and paper work

Increase traceability and easily manage your data

Data in real-time and extracted customisable PDFs for actionable insights

Testing Mevia’s solutions

Case studies

Case study 1:

In a home care setting, Mevia's solutions were used on 21 residents between the ages of 75 and 90. During the 3-month study, medical deviation decreased from 60% to 14% compared to the same period the year before.

Case study 2:

Fifteen subjects over 80 years of age used Mevia's solutions with placebo medication in multi-dose packages for 4 weeks. With the support of the application, the adherence was 87%.

Download study
A pie chart with 60% red
Adherence deviation
without Mevia’s solution
A pie chart with 14% green
Adherence deviation
with Mevia’s solution
A pie chart with 97% green
Accuracy that the pill actually is taken when it has been taken out from the package.

Is the dose really taken?

Our solutions use electronic monitoring to measure when a pill is taken out from the package. When taken out from the package, studies confirm that 97% also consumes the pill.

Reference: M.Burnier (2019) Is there a threshold for medication adherence? Lessons learnt from electronic monitoring of drug Adherence

Is the dose really taken?

Our solutions use electronic monitoring to measure when a pill is taken out from the package. When taken out from the package, studies confirm that 97% also consumes the pill.

Reference: M.Burnier (2019) Is there a threshold for medication adherence? Lessons learnt from electronic monitoring of drug Adherence
A pie chart with 97% green
Accuracy that the pill actually is taken when it has been taken out from the package.